Camilla Canepa died on Thursday aged 18 after being given the vaccine on May 25, triggering a storm of controversy in Italy over the Anglo-Swedish brand being given to adults of all ages despite previously-raised medical concerns.
"AstraZeneca will only be used for people over 60," the country's special COVID commissioner Francesco Figliuolo told reporters at a news conference.